Long term disease-free survival resulting from combined modality management of patients presenting with oligometastatic, non-small cell lung carcinoma (NSCLC)

被引：76

作者：

Khan, Atif J.

Mehta, Par S.

Zusag, Thomas W.

Bonomi, Philip D.

Faber, L. Penfield

Shott, Susan

Abrams, Ross A.

机构：

[1] Rush Univ, Med Ctr, Dept Radiat Oncol, Chicago, IL 60612 USA

[2] Rush Univ, Med Ctr, Dept Internal Med, Sect Med Oncol, Chicago, IL 60612 USA

[3] Rush Univ, Med Ctr, Dept Surg, Chicago, IL 60612 USA

来源：

RADIOTHERAPY AND ONCOLOGY | 2006年 / 81卷 / 02期

关键词：

lung cancer; NSCLC; oligometastasis; oligometastases;

D O I：

10.1016/j.radonc.2006.09.006

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

We report outcomes on 23 patients with oligometastastic (1 or 2 sites) NSCLC treated with aggressive local, regional, and systemic treatment. The results suggest that this is a favorable subset of patients who may benefit from such an approach, with a 22% rate of long-term survival. This treatment strategy is a departure from the usual practice of palliative-only therapy for all NSCLC patients presenting with metastatic disease. (c) 2006 Elsevier Ireland Ltd. All rights reserved.

引用

收藏

页码：163 / 167

页数：5

相关论文

共 24 条

[1] Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial [J].

Andrews, DW ;

Scott, CB ;

Sperduto, PW ;

Flanders, AE ;

Gaspar, LE ;

Schell, MC ;

Werner-Wasik, M ;

Demas, W ;

Ryu, J ;

Bahary, JP ;

Souhami, L ;

Rotman, M ;

Mehta, MP ;

Curran, WJ .

LANCET, 2004, 363 (9422) :1665-1672

[2] Surgical management of non-small cell lung cancer with synchronous brain metastases [J].

Bonnette, P ;

Puyo, P ;

Gabriel, C ;

Giudicelli, R ;

Regnard, JF ;

Riquet, M ;

Brichon, PY .

CHEST, 2001, 119 (05) :1469-1475

[3] CISPLATIN CYCLOPHOSPHAMIDE MITOMYCIN COMBINATION CHEMOTHERAPY WITH SUPPORTIVE CARE VERSUS SUPPORTIVE CARE ALONE FOR TREATMENT OF METASTATIC NON-SMALL-CELL LUNG-CANCER [J].

CARTEI, G ;

CARTEI, F ;

CANTONE, A ;

CAUSARANO, D ;

GENCO, G ;

TOBALDIN, A ;

INTERLANDI, G ;

GIRALDI, T .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (10) :794-800

[4] Long-term survival after surgical resections of bronchogenic carcinoma and adrenal metastasis [J].

de Perrot, M ;

Licker, M ;

Robert, JH ;

Spiliopoulos, A .

ANNALS OF THORACIC SURGERY, 1999, 68 (03) :1084-1085

[5]

*ELD LUNG CANC VIN, 1999, JNCI-J NATL CANCER I, V691, P66

[6]

Hauser J, 2003, P AN M AM SOC CLIN, P22

[7] Evaluation of the treatment of non-small cell lung cancer with brain metastasis and the role of risk score as a survival predictor [J].

Iwasaki, A ;

Shirakusa, T ;

Yoshinaga, Y ;

Enatsu, S ;

Yamamoto, M .

EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2004, 26 (03) :488-493

[8] Cancer statistics, 2005 [J].

Jemal, A ;

Murray, T ;

Ward, E ;

Samuels, A ;

Tiwari, RC ;

Ghafoor, A ;

Feuer, EJ ;

Thun, MJ .

CA-A CANCER JOURNAL FOR CLINICIANS, 2005, 55 (01) :10-30

[9] Successful treatment of solitary extracranial metastases from non-small cell lung cancer [J].

Luketich, JD ;

Martini, N ;

Ginsberg, RJ ;

Rigberg, D ;

Burt, ME .

ANNALS OF THORACIC SURGERY, 1995, 60 (06) :1609-1611

[10] Does resection of adrenal metastases from non-small cell lung cancer improve survival? [J].

Luketich, JD ;

Burt, ME .

ANNALS OF THORACIC SURGERY, 1996, 62 (06) :1614-1616